Viewing Study NCT05749237



Ignite Creation Date: 2024-05-06 @ 6:41 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05749237
Status: RECRUITING
Last Update Posted: 2023-03-01
First Post: 2023-02-17

Brief Title: The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma
Sponsor: Istanbul University - Cerrahpasa IUC
Organization: Istanbul University - Cerrahpasa IUC

Study Overview

Official Title: The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma
Status: RECRUITING
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PHASTER
Brief Summary: The goal of this randomized placebo controlled study is to evaluate the effect of respiratory exercises on asthma attack frequency symptom and medication scores and quality of life of children with a diagnosis of asthma

Participants will be asked to perform respiratory exercises described at once in hospital at home regularly Control group will comprised children with asthma without respiratory exercises
Detailed Description: At the beginning of the study anthropometric measurements basal respiratory function assessment drugs demographic information allergen sensitivity asthma control levels and quality of life scales will be documented Patients will be randomly divided into two groups one group following respiratory exercises and relaxation exercises and the other following only relaxation exercises Both groups will be called regularly to remind the exercises

The spirometric tests and asthma control forms will be reevaluated at the 3rd and 6th month at hospital

Peak flow meters will be given to patients to document PEF values during study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None